Home > Healthcare > Medical Devices > Diagnostic Devices > Biological Imaging Reagents Market

Biological Imaging Reagents Market Size

  • Report ID: GMI10770
  • Published Date: Aug 2024
  • Report Format: PDF

Biological Imaging Reagents Market Size

Biological Imaging Reagents Market size was valued at USD 12.2 billion in 2023 and is anticipated to witness growth at a CAGR of 7.3% between 2024 and 2032, driven by factors such as the increasing prevalence of chronic conditions coupled with substantial investments in research and development.

 

The increasing prevalence of chronic conditions is driving the growth of the biological imaging reagents market as these conditions necessitate advanced imaging techniques for early diagnosis, effective monitoring, and treatment evaluation. A sedentary lifestyle, poor diet, and rising obesity rates are major contributors to the growing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancer.
 

For instance, according to the World Health Organization (WHO) report in 2022, chronic diseases are responsible for 71% of all global deaths, with cardiovascular diseases, cancers, and diabetes being the leading causes. This increasing prevalence underscores the demand for biological imaging reagents to enhance diagnostic accuracy and treatment efficacy in the face of rising chronic health challenges. 
 

Biological imaging reagents are specialized substances used to enhance the visualization of biological processes, structures, or tissues in various imaging techniques. These reagents include a wide range of chemicals, dyes, contrast agents, and probes that interact with biological targets to provide detailed images, facilitating the study and diagnosis of diseases, as well as the exploration of biological functions.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of biological imaging reagents reached USD 12.2 billion in 2023 and is set to register 7.3% CAGR between 2024 and 2032, due to increasing prevalence of chronic conditions and substantial investments in R&D.

The clinical diagnostics segment is projected to reach USD 9.7 billion by 2032, driven by the need for enhancing the accuracy, sensitivity, and specificity of various imaging modalities.

North America market accounted for USD 4.7 billion in in 2023, led by advanced healthcare infrastructure and significant R&D investments.

Bayer AG, Bracco, Carl Zeiss, Cell Signaling Technology, Danaher, General Electric Company, Guerbet, Jubilant Pharmova Limited, Luminex Corporation, and Nikon Corporation, among others.

Biological Imaging Reagents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 214
  • Countries covered: 23
  • Pages: 110
 Download Free Sample